Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

Explore

Strain Directory Indica Strains Sativa Strains Hybrid Strains Breeders

Research

Research Database Medical Conditions Pain Relief Anxiety Insomnia

Tools

Strain Comparator Strain Explorer Blog API

© 2026 BudProfiles. For informational and educational purposes only.

Privacy Policy Terms of Service Disclaimer

11,121 strains · 12,304 studies · 268 breeders

Best Cannabis Strains for ADD and ADHD — 0 Strains, 0 Studies | BudProfiles

Home

Conditions

ADD and ADHD

Cannabis & ADD and ADHD

Explore 0 strains and 0 scientific studies related to ADD and ADHD.

0

Strains

0

Studies

7

Positive Studies

42%

Evidence Score

Research Evidence

7

Positive (35.0%)

9

Negative (45.0%)

4

Inconclusive (20.0%)

Scientific Studies

The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis

2024·Meta-analysis -

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

2024·Review/Other

Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management

2024·Animal Study - Veterinary Clinical Trial

Examining the association between prenatal cannabis exposure and child autism traits: A multi-cohort investigation in the environmental influences on child health outcome program

2024·Review/Other

A systematic review of cannabidiol trials in neurodevelopmental disorders

2023·Clinical Trial

Cannabis use in Attention - Deficit/Hyperactivity Disorder (ADHD): A scoping review

2023·Review/Other

Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county

2023·Review/Other

CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study

2023·Double Blind Clinical Trial

E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

2022·Review/Other

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

2022·Clinical Trial

Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

2022·Review/Other

Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model

2022·Animal Study -

Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort

2022·Review/Other

Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives

2022·Review/Other

Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder

2022·Review/Other

The effect of medical cannabis on cognitive functions: a systematic review

2022·Meta-analysis -

Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents

2022·Review/Other

Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

2022·Double Blind Clinical Trial

Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases

2022·Review/Other

Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort

2022·Review/Other